CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Board of Directors bought 10,000 shares at $0.80 ($7,970)
- 4 Open-market buy President and CEO bought 30,000 shares at $0.81 ($24,300)
- 8-K Event Shareholder vote results
- 4 Open-market buy President and CEO bought 10,000 shares at $0.78 ($7,800)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- DEFR14A Other DEFR14A
- 8-K Event Delisting notice
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
Page 28 of 38 · 742 filings